Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
70.09% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
APP · Mar 31, 2026
AppLovin Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001751008-26-000044General Corporate
Evidence method
Level · gp.fundamentals.gross_margin
88.95% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
78.15% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.11% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
4.53% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History5 statesHistory building
Period transition
What moved in the state?
- Previous
- 72.46%
- Current
- 70.09%
- Delta
- -2.36%
- Previous
- 87.86%
- Current
- 88.95%
- Delta
- 1.08%
- Previous
- 75.75%
- Current
- 78.15%
- Delta
- 2.40%
- Previous
- 4.13%
- Current
- 5.11%
- Delta
- 0.97%
- Previous
- 3.84%
- Current
- 4.53%
- Delta
- 0.69%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Has State · AppLovin Corp →Transitioned To · APP Fundamental State →Transitioned To · APP CASH_GENERATION_DECREASED →Transitioned To · APP MARGIN_INCREASED →Transitioned To · APP PROFITABILITY_INCREASED →Transitioned To · APP R_AND_D_INTENSITY_INCREASED →Transitioned To · APP SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.